Journal ArticleDOI
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus
Dean J. Kereiakes,Dean J. Kereiakes,Gilles Montalescot,Gilles Montalescot,Elliott M. Antman,Elliott M. Antman,Marc Cohen,Marc Cohen,Harald Darius,Harald Darius,James J. Ferguson,James J. Ferguson,Cindy Grines,Cindy Grines,Karl R. Karsch,Karl R. Karsch,Neal S. Kleiman,Neal S. Kleiman,David J. Moliterno,David J. Moliterno,Phillippe Gabriel Steg,Phillippe Gabriel Steg,Paul S. Teirstein,Paul S. Teirstein,Frans Van de Werf,Frans Van de Werf,Lars Wallentin,Lars Wallentin +27 more
TLDR
Substantial evidence exists that patients receiving LMWH for an ACS can safely undergo cardiac catheterization and percutaneous coronary intervention, and concerns regarding the transition of these patients from the medical service to the cardiacCatheterization laboratory should not impede the upstream use of LMWH.About:
This article is published in American Heart Journal.The article was published on 2002-10-01. It has received 59 citations till now. The article focuses on the topics: Heart catheterization & Percutaneous coronary intervention.read more
Citations
More filters
Journal ArticleDOI
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
TL;DR: The American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions (ACC/AHA/SCAI) 2005 Guideline Update for Percutaneous Coronary Intervention (PCI) contains changes in the recommendations, along with supporting text.
Journal Article
Aspirin, heparin, or both to treat acute unstable angina
Pierre Théroux,H. Ouimet,John McCans,J.-G. Latour,P. Joly,G. Levy,E. Pelletier,Martin Juneau,J. Stasiak,P. DeGuise,Guy B. Pelletier,D. Rinzler,David D. Waters +12 more
TL;DR: In this article, the usefulness of aspirin (325 mg twice daily), heparin (1000 units per hour by intravenous infusion), and a combination of the two in the early management of acute unstable angina pectoris in a double-blind, randomized, placebo-controlled trial involving 479 patients was tested.
Journal ArticleDOI
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
Journal Article
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-summary article : A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
TL;DR: WRITING COMMITTEE MEMBERS Sidney C. Smith, Jr, MD, F ACC, FAHA, Chair; Ted E. O’Neill,MD, FACC, FSCAI; Hartzell V. Schaff, MD; Patrick L. Whitlow,MD; David O. Williams, MD.
Journal ArticleDOI
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.
Kazuo Kimura,Takeshi Kimura,Masaharu Ishihara,Yoshihisa Nakagawa,Koichi Nakao,Katsumi Miyauchi,Tomohiro Sakamoto,Kenichi Tsujita,Nobuhisa Hagiwara,Shunichi Miyazaki,Junya Ako,Hirokuni Arai,Hideki Ishii,Hideki Origuchi,Wataru Shimizu,Hirofumi Takemura,Yoshio Tahara,Yoshihiro Morino,Kenji Iino,Tomonori Itoh,Yoshitaka Iwanaga,Keiji Uchida,Hirohisa Endo,Ken Kongoji,Kenji Sakamoto,Hiroki Shiomi,Takao Shimohama,Atsushi Suzuki,Jun Takahashi,Ichiro Takeuchi,Akihito Tanaka,Toshihiro Tamura,Takahiro Nakashima,Teruo Noguchi,Daisuke Fukamachi,Tomohiro Mizuno,Junichi Yamaguchi,Kenji Yodogawa,Masami Kosuge,Shun Kohsaka,Hideaki Yoshino,Satoshi Yasuda,Hiroaki Shimokawa,Atsushi Hirayama,Takashi Akasaka,Kazuo Haze,Hisao Ogawa,Hiroyuki Tsutsui,Tsutomu Yamazaki +48 more
TL;DR: This document is an English version of JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome reported at the Japanese Circulation Society Joint Working Groups performed in 2018.
References
More filters
Journal ArticleDOI
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina)
Eugene Braunwald,Elliott M. Antman,John W. Beasley,Robert M. Califf,Melvin D. Cheitlin,Judith S. Hochman,Robert H. Jones,Dean J. Kereiakes,Joel Kupersmith,Thomas N. Levin,Carl J. Pepine,John W. Schaeffer,Earl E. Smith,David E Steward,Pierre Theroux,Raymond J. Gibbons,Joseph S. Alpert,David P. Faxon,Valentin Fuster,Gabriel Gregoratos,Loren F. Hiratzka,Alice K. Jacobs,Sidney C. Smith +22 more
TL;DR: The present guidelines supersede the 1994 guidelines and summarize both the evidence and expert opinion and provide final recommendations for both patient evaluation and therapy.
Journal ArticleDOI
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.
TL;DR: Ischemic complications of coronary angioplasty and atherectomy were reduced with a monoclonal antibody directed against the platelet IIb/IIIa glycoprotein receptor, although the risk of bleeding was increased.
Journal ArticleDOI
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
TL;DR: Inhibition of the platelet glycoprotein IIb/IIIa receptor with abciximab, together with low-dose, weight-adjusted heparin, markedly reduces the risk of acute ischemic complications in patients undergoing percutaneous coronary revascularization, without increasing the riskof hemorrhage.
Journal ArticleDOI
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
Marc Cohen,Christine Demers,Enrique P. Gurfinkel,A.G.G Turpie,Gregg J Fromell,Shaun G Goodman,Anatoly Langer,Robert M. Califf,Keith A.A. Fox,J. Premmereur,Frederique Bigonzi +10 more
TL;DR: Antithrombotic therapy with enoxaparin plus aspirin was more effective than unfractionated heparin plus aspirin in reducing the incidence of ischemic events in patients with unstable angina or non-Q-wave myocardial infarction in the early phase.
Journal ArticleDOI
Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.
TL;DR: Platelet glycoprotein-IIb/IIIa blockade with abciximab substantially improves the safety of coronary-stenting procedures and is safer than stenting without abcximab.
Related Papers (5)
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention: REPLACE-2 Randomized Trial
A. Michael Lincoff,John A. Bittl,Robert A. Harrington,Frederick Feit,Neal S. Kleiman,J. Daniel Jackman,Ian J. Sarembock,David J. Cohen,Douglas Spriggs,Ramin Ebrahimi,Gadi Keren,Jeffrey Carr,Eric A. Cohen,Amadeo Betriu,Walter Desmet,Dean J. Kereiakes,Wolfgang Rutsch,Robert G. Wilcox,Pim J. de Feyter,Alec Vahanian,Eric J. Topol +20 more